Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: Viral RNA persists through formation of a double- stranded complex without associated genomic mutations or evolution

Journal of Virology

Volumn 73, Issue 12, 1999, Pages 10113-10121

  Tam, Patricia E ^a   Messner, Ronald P ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; VIRUS RNA;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; COXSACKIE VIRUS; EVOLUTION; MOLECULAR BIOLOGY; MOUSE; MYOPATHY; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0032737032     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.12.10113-10121.1999     Document Type: Article

References (53)

1. Andreoletti, L., D. Hober, P. Becquart, S. Belaich, M. C. Copin, V. Lambert, and P. Wattre. 1997. Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocardial damage in persistent cardiac infection. J. Med. Virol. 52: 206-214.
2. Arbustini, E., M. Grasso, E. Porcu, O. Bellini, M. Diegoli, R. Fasani, N. Banchieri, A. Pilotto, P. Morbini, B. Dal Bello, C. Campana, A. Gavazzi, and M. Vigano. 1997. Enteroviral RNA and virus-like particles in the skeletal muscle of patients with idiopathic dilated cardiomyopathy. Am. J. Cardiol. 80:1188-1193.
3. Archard, L. C., N. E. Bowles, L. Cunningham, C. A. Freeke, E. G. Olsen, M. L. Rose, B. Meany, H. J. Why, and P. J. Richardson. 1991. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur. Heart J. 12(Suppl. D):56-59.
4. Berger, M. M., D. M. See, M. Aymard, and B. Lina. 1998. Demonstration of persistent enterovirus in the pancreas of diabetic mice by in situ polymerase chain reaction. Clin. Diagn. Virol. 9:141-143.
5. Borzakian, S., T. Couderc, Y. Barbier, G. Attal, I. Pelletier, and G. F. Colbere. 1992. Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms. Virology 184:398-408.
6. Borzakian, S., I. Pelletier, V. Calvez, and F. Colbere-Garapin. 1993. Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells. J. Virol. 67:2914-2917.
7. Bowles, N. E., T. A. Bayston, H. Y. Zhang, D. Doyle, R. J. Lane, L. Cunningham, and L. C. Archard. 1993. Persistence of enterovirus RNA in muscle biopsy samples suggests that some cases of chronic fatigue syndrome result from a previous, inflammatory viral myopathy. J. Med. 24:145-160.
8. Bowles, N. E., V. Dubowitz, C. A. Sewry, and L. C. Archard. 1987. Dermatomyositis, polymyositis, and Coxsackie-B-virus infection. Lancet i:1004-1007.
9. Bowles, N. E., P. J. Richardson, E. G. Olsen, and L. C. Archard. 1986. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet i:1120-1123.
10. Cao, Y., and D. P. Schnurr. 1988. Persistent infection of YAC-1 cells by coxsackievirus B3. J. Gen. Virol. 69:59-65.
11. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
12. Colbere-Garapin, F., G. Duncan, N. Pavio, I. Pelletier, and I. Petit. 1998. An approach to understanding the mechanisms of poliovirus persistence in infected cells of neural or non-neural origin. Clin. Diagn. Virol. 9: 107-113.
13. Conaldi, P. G., C. Serra, A. Mossa, V. Falcone, F. Basolo, G. Camussi, A. Dolei, and A. Toniolo. 1997. Persistent infection of human vascular endothelial cells by group B coxsackieviruses. J. Infect. Dis. 175:693-696.
14. Correa-Rotter, R., C. N. Mariash, and M. E. Rosenberg. 1992. Loading and transfer control for Northern hybridization. BioTechniques 12:154-158.
15. Cunningham, L., N. E. Bowles, R. J. Lane, V. Dubowitz, and L. C. Archard. 1990. Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J. Gen. Virol. 71:1399-1402.
16. Fohlman, J., G. Friman, and T. Tuvemo. 1997. Enterovirus infections in new disguise. Lakartidningen 94:2555-2560.
17. Galbraith, D. N., C. Nairn, and G. B. Clements. 1997. Evidence for enteroviral persistence in humans. J. Gen. Virol. 78:307-312.
18. Gow, J. W., W. M. Behan, P. Cash, K. Simpson, and P. O. Behan. 1997. Genomic and template RNA transcription in a model of persistent enteroviral infection. J. Neurovirol. 3:76-82.
19. Graeber, I., J. Tischer, J. Heinrich, G. Hachula, and J. M. Lopez-Pila. 1998. Persistence of heterologous nucleic acids after uptake by mammalian cells. DNA Cell Biol. 17:945-949.
20. Hickie, I., and A. Lloyd. 1995. Are cytokines associated with neuropsychiatrie syndromes in humans? Int. J. Immunopharmacol. 17:677-683.
21. Hohenadl, C., K. Klingel, J. Mertsching, P. H. Hofschneider, and R. Kandolf. 1991. Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization. Mol. Cell. Probes 5:11-20.
22. Holland, J., K. Spindler, F. Horodyski, E. Grabau, S. Nichol, and S. Vande-Pol. 1982. Rapid evolution of RNA genomes. Science 215:1577-1585.
23. Iizuka, N., S. Kuge, and A. Nomoto. 1987. Complete nucleotide sequence of the genome of coxsackievirus B1. Virology 156:64-73.
24. Iwahana, H., K. Yoshimoto, and M. Itakara. 1992. Detection of point mutations by SSCP of PCR-amplified DNA after endonuclease digestion. BioTechniques 12:64-66.
25. Jacobs, B. L., and J. O. Langland. 1996. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219:339-349.
26. Klingel, K., S. Stephan, M. Sauter, R. Zell, B. M. McManus, B. Bultmann, and R. Kandolf. 1996. Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J. Virol. 70:8888-8895.
27. Leparc-Goffart, I., J. Julien, F. Fuchs, I. Janatova, M. Aymard, and H. Kopecka. 1996. Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome. J. Clin. Microbiol. 34:2023-2026.
28. Liu, Q., and S. S. Sommer. 1995. Restriction endonuclease fingerprinting (REF): a sensitive method for screening mutations in long, contiguous segments of DNA. BioTechniques 18:470-477.
29. Matteucci, D., M. Paglianti, A. M. Giangregorio, M. R. Capobianchi, F. Dianzani, and M. Bendinelli. 1985. Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines. J. Virol. 56:651-654.
30. McKinney, R. E., Jr., S. L. Katz, and C. M. Wilfert. 1987. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev. Infect. Dis. 9:334-356.
31. McLaren, J., E. Argo, and P. Cash. 1993. Evolution of coxsackie B virus during in vitro persistent infection: detection of protein mutations using two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 14:137-147.
32. Melchers, W., J. Zoll, F. van Kuppeveld, C. Swanink, and J. Galama. 1994. There is no evidence for persistent enterovirus infections in chronic medical conditions in humans. Rev. Med. Virol. 4:235-243.
33. Muir, P., and L. C. Archard. 1994. There is evidence for persistent enterovirus infections in chronic medical conditions in humans. Rev. Med. Virol. 4:245-250.
34. 33a.National Institutes of Health. 7 June 1999, revision date. Image analysis software. [Online.] http://rsb.info.nih.gov/nih-image/. [8 October 1999, last date accessed.]
35. Parker, L. T., H. Zakeri, Q. Deng, S. Spurgeon, P.-Y. Kwok, and D. A. Nickerson. 1996. AmpliTaq DNA polymerase, FS dye-terminator sequencing: analysis of peak height patterns. BioTechniques 21:694-699.
36. Pelletier, I., G. Duncan, N. Pavio, and F. Colbere-Garapin. 1998. Molecular mechanisms of poliovirus persistence: key role of capsid determinants during the establishment phase. Cell. Mol. Life Sci. 54:1385-1402.
37. Rantanen, J., J. Ranne, T. Hurme, and H. Kallmo. 1995. Denervated segments of injured skeletal muscle fibers are reinnervated by newly formed neuromuscular junctions. J. Neuropathol. Exp. Neurol. 54:188-194.
38. Ray, C. G., L. L. Minnich, and P. C. Johnson. 1979. Selective polymyositis induced by coxsackievirus B1 in mice. J. Infect. Dis. 140:239-243.
39. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
40. Schnurr, D. P., and N. J. Schmidt. 1984. Persistent infection of mouse fibroblasts with Coxsackievirus. Arch. Virol. 81:91-101.
41. Strongwater, S. L., K. Dorovini-Zis, R. D. Ball, and T. J. Schnitzer. 1984. A murine model of polymyositis induced by coxsackievirus B1 (Tucson strain). Arthritis Rheum. 27:433-442.
42. Tam, P. E., and R. M. Messner. 1996. Genetic determinants of susceptibility to coxsackievirus B1-induced chronic inflammatory myopathy: effects of host background and major histocompatibility complex genes. J. Lab. Clin. Med. 128:279-289.
43. Tam, P. E., and R. P. Messner. 1997. Coxsackievirus-induced chronic inflammatory myopathy: virus variants distinguish between acute cytopathic effects and pathogenesis of chronic disease. Virology 233:199-209.
44. Tam, P. E., A. M. Schmidt, and R. P. Messner. 1993. Modified tissue pulverization technique and evaluation of dihydrofolate reductase amplification as a pan-tissue RT-PCR control. PCR Methods Applic. 3:71-72.
45. Tam, P. E., A. M. Schmidt, S. R. Ytterberg, and R. P. Messner. 1994. Duration of virus persistence and its relationship to inflammation during the chronic phase of coxsackievirus B1-induced murine polymyositis. J. Lab. Clin. Med. 123:345-356.
46. Tam, P. E., A. M. Schmidt, S. R. Ytterberg, and R. P. Messner. 1991. Viral persistence during the developmental phase of coxsackievirus B1-induced murine polymyositis. J. Virol. 65:6654-6660.
47. Vella, C., C. L. Brown, and D. A. McCarthy. 1992. Coxsackievirus B4 infection of the mouse pancreas: acute and persistent infection. J. Gen. Virol. 73:1387-1394.
48. Wessely, R., A. Henke, R. Zell, R. Kandolf, and K. U. Knowlton. 1998. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 98:450-457.
49. Wessely, R., K. Klingel, L. F. Santana, N. Dalton, M. Hongo, W. Jonathan Lederer, R. Kandolf, and K. U. Knowlton. 1998. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J. Clin. Investig. 102:1444-1453.
50. Woodall, C. J., M. H. Riding, D. I. Graham, and G. B. Clements. 1994. Sequences specific for enterovirus detected in spinal cord from patients with motor neurone disease. Br. Med. J. 308:1541-1543.
51. Ytterberg, S. R., M. L. Mahowald, and R. P. Messner. 1987. Coxsackievirus B1-induced polymyositis. Lack of disease expression in nu/nu mice. J. Clin. Investig. 80:499-596.
52. Ytterberg, S. R., M. L. Mahowald, and R. P. Messner. 1988. T cells are required for coxsackievirus B1 induced murine polymyositis. J. Rheumatol. 15:475-478.
53. Zintz, C. B., and D. C. Beebe. 1991. Rapid reamplification of PCR products purified in low melting point agarose gels. BioTechniques 11:158-162.